The introduction of nicotinamide being a nicotine substitute in e-cigarette and smokeless products and solutions represents a substantial regulatory challenge to the FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is thought to act as a sedative at higher dosages6. The promises created by Nicotine River, ECBlend, and also ot